The postoperative occurrence or worsening of diabetes mellitus may increase the risk of recurrence in resected pancreatic neuroendocrine tumors. de Mestier, L.; Vedie, A. L.; Faron, M.; Cros, J.; Rebours, V.; Hentic, O.; Do Cao, C.; Bardet, P.; Levy, P.; Sauvanet, A.; Ruszniewski, P.; Hammel, P.. Neuroendocrinology. 2019; : . doi:10.1159/000505158Article